- Home
- Publications
- Publication Search
- Publication Details
Title
Severe hypertriglyceridemia: Existing and emerging therapies
Authors
Keywords
-
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 251, Issue -, Pages 108544
Publisher
Elsevier BV
Online
2023-10-15
DOI
10.1016/j.pharmthera.2023.108544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies
- (2023) Waqas A. Malick et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial
- (2023) Robert S. Rosenson et al. NATURE MEDICINE
- The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial
- (2023) Deepak L. Bhatt et al. NATURE MEDICINE
- Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
- (2023) Rohit Loomba et al. NEW ENGLAND JOURNAL OF MEDICINE
- An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif
- (2022) Deepa Balasubramaniam et al. JOURNAL OF LIPID RESEARCH
- A Biological Rationale for the Disparate Effects of Omega-3 Fatty Acids on Cardiovascular Disease Outcomes
- (2022) Samuel C.R. Sherratt et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy
- (2022) Mingjuan Deng et al. JOURNAL OF LIPID RESEARCH
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidance for the diagnosis and treatment of hypolipidemia disorders
- (2022) Cindy Bredefeld et al. Journal of Clinical Lipidology
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- (2022) Aruna Das Pradhan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction
- (2021) Aleesha Shaik et al. CARDIOVASCULAR DRUGS AND THERAPY
- Effects of liraglutide on the metabolism of triglyceride‐rich lipoproteins in type 2 diabetes
- (2021) Marja‐Riitta Taskinen et al. DIABETES OBESITY & METABOLISM
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- GLP-1 (Glucagon-Like Peptide-1) Is Physiologically Relevant for Chylomicron Secretion Beyond Its Known Pharmacological Role
- (2021) Avital Nahmias et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B
- (2021) Nick S. Nurmohamed et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2021) Ioanna Gouni-Berthold et al. Lancet Diabetes & Endocrinology
- Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects
- (2021) Graziella E. Ronsein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
- (2021) Henry N Ginsberg et al. EUROPEAN HEART JOURNAL
- Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction
- (2021) Anette Varbo et al. EUROPEAN HEART JOURNAL
- Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia
- (2021) Zahid Ahmad et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
- (2021) Salim S. Virani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis
- (2021) Robert J. Sanchez et al. Lipids in Health and Disease
- New Therapies for Lowering Triglyceride-Rich Lipoproteins
- (2021) Robert S. Rosenson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alcohol effects on hepatic lipid metabolism
- (2020) Sookyoung Jeon et al. JOURNAL OF LIPID RESEARCH
- Angiopoietin-like protein 3 (ANGPTL3) governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
- (2020) Rene C. Adam et al. JOURNAL OF LIPID RESEARCH
- Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
- (2020) Yan Q. Chen et al. JOURNAL OF LIPID RESEARCH
- Genetics of Hypertriglyceridemia
- (2020) Jacqueline S. Dron et al. Frontiers in Endocrinology
- The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
- (2020) Jan Borén et al. Frontiers in Endocrinology
- LDL-Cholesterol Reduction by ANGPTL3 Inhibition in Mice Is Dependent on Endothelial Lipase
- (2020) Liya Wu et al. CIRCULATION RESEARCH
- A Comprehensive Update on the Chylomicronemia Syndrome
- (2020) Ronald B. Goldberg et al. Frontiers in Endocrinology
- Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease
- (2020) Edward K Duran et al. CLINICAL CHEMISTRY
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- (2020) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
- (2019) Veronica J Alexander et al. EUROPEAN HEART JOURNAL
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
- (2019) Zahid Ahmad et al. CIRCULATION
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
- (2019) Ann C. Skulas-Ray et al. CIRCULATION
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice
- (2019) Antwi-Boasiako Oteng et al. JOURNAL OF LIPID RESEARCH
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- APOC3Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular RiskHighlights
- (2018) Anders B. Wulff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
- (2018) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance
- (2017) Jorge F. Haller et al. JOURNAL OF LIPID RESEARCH
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues
- (2016) Christian Schlein et al. Cell Metabolism
- Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism
- (2016) Satya Dash et al. CURRENT OPINION IN LIPIDOLOGY
- Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
- (2016) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis
- (2016) Simon B. Pedersen et al. JAMA Internal Medicine
- Hypertriglyceridemia in the Genomic Era: A New Paradigm
- (2015) Gary F. Lewis et al. ENDOCRINE REVIEWS
- Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases
- (2015) Fangfang Zhang et al. MOLECULAR ENDOCRINOLOGY
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
- (2013) John J.P. Kastelein et al. Journal of Clinical Lipidology
- Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management
- (2013) Jooho Lee et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Severe Hypertriglyceridemia With Pancreatitis
- (2013) Frank M. Sacks et al. JAMA Internal Medicine
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity
- (2012) Martin Adiels et al. ATHEROSCLEROSIS
- Postprandial metabolism of meal triglyceride in humans
- (2012) Jennifer E. Lambert et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Role of the Gut in Lipid Homeostasis
- (2012) Nada A. Abumrad et al. PHYSIOLOGICAL REVIEWS
- Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
- (2011) Harold E. Bays et al. AMERICAN JOURNAL OF CARDIOLOGY
- An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia
- (2011) Christopher T. Johansen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Allelic and phenotypic spectrum of plasma triglycerides
- (2011) Christopher T. Johansen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- The mechanism of the formation and secretion of chylomicrons
- (2010) Tammy Kindel et al. ATHEROSCLEROSIS SUPPLEMENTS
- Genetic determinants of plasma triglycerides
- (2010) Christopher T. Johansen et al. JOURNAL OF LIPID RESEARCH
- Exome Sequencing,ANGPTL3Mutations, and Familial Combined Hypolipidemia
- (2010) Kiran Musunuru et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prescription Omega-3 Fatty Acid as an Adjunct to Fenofibrate Therapy in Hypertriglyceridemic Subjects
- (2009) Eli M Roth et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started